MEI Pharma(MEIP) - 2026 Q2 - Quarterly Results
MEI PharmaMEI Pharma(US:MEIP)2026-02-17 13:50

Financial Results - Lite Strategy, Inc. reported financial results for the three and six months ended December 31, 2025[6]. - The press release detailing the financial results was issued on February 17, 2026[6]. - The report does not include specific financial figures or performance metrics in the provided content[6]. - The filing does not include any financial statements or detailed exhibits[7]. - The report is not deemed "filed" under the Securities Exchange Act of 1934[6]. Company Information - The company is listed on The Nasdaq Stock Market under the symbol LITS[5]. - The company has not indicated whether it is an emerging growth company[5]. - The CEO and CFO of Lite Strategy, Inc. is Justin J. File[11]. - The address of the company's principal executive offices is 9920 Pacific Heights Blvd., Suite 150, San Diego, California 92121[2]. Product and Market Activity - No new products, technologies, market expansions, or acquisitions were mentioned in the available content[6].

MEI Pharma(MEIP) - 2026 Q2 - Quarterly Results - Reportify